MedTrace Logo

Intervention Study to Improve Antibiotic Prescription in Outpatient Care

NCT01358916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2013-03-29

No results posted yet for this study

Summary

Antimicrobial resistance has become a world-wide problem and antibiotic consumption is a major driving force for the development of resistance. Thus optimization of antibiotic prescription and reduction of unnecessary antimicrobial treatment are essential in the prevention and reduction of antimicrobial resistance rates.

The goal of this study is the improvement of antibiotic prescription in outpatient care. The study will take place within a Swiss-wide sentinel surveillance network of physicians. The participating physicians will be randomised in a control and intervention group. The intervention group will receive therapeutic guidelines for the treatment of upper and lower respiratory tract infections and lower urinary tract infection as well as regular feed-backs on the prescription pattern of the sentinel physicians during the past months. Sentinel physicians will collect information about each antibiotic prescription, its indication and characteristics of the patient.

Our hypothesis is that the prescription pattern in the intervention group will be optimised and unnecessary antibiotic therapy will be reduced compared to the control group.

Conditions

Interventions

OTHER

Mailing of antibiotic therapy guidelines to the sentinel physicians

Mailing of antibiotic therapy guidelines to the sentinel physicians and regular feedback on antibiotic prescription

Sponsors & Collaborators

  • Bundesamt für Gesundheit

    collaborator UNKNOWN

  • Sentinella Netzwerk

    collaborator UNKNOWN

  • Schweizerische Gesellschaft für Infektiologie

    collaborator UNKNOWN

  • Pädiatrische Infektiologie Gruppe Schweiz

    collaborator UNKNOWN

  • University of Bern

    lead OTHER

Principal Investigators

  • Andreas Kronenberg, Dr. med. · University of Bern

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01358916 on ClinicalTrials.gov